Učitavanje...
A novel preclinical method to quantitatively evaluate early-stage metastatic events at the murine blood-brain barrier
The observation that approximately 15% of women with disseminated breast cancer will develop symptomatic brain metastases combined with treatment guidelines discouraging single-agent chemotherapeutic strategies facilitates the desire for novel strategies aimed at outright brain metastasis prevention...
Spremljeno u:
Izdano u: | Cancer Prev Res (Phila) |
---|---|
Glavni autori: | , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
2014
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4311570/ https://ncbi.nlm.nih.gov/pubmed/25348853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-14-0225 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|